Adherence to Anti-Retroviral Therapy (ART) and Its Determinants Among People Living with HIV/AIDS at Bonga, Kaffa, South-West Ethiopia
Asrat Tekle,Arega Tsegaye,Tsige Ketema
DOI: https://doi.org/10.2147/ppa.s445164
2024-03-06
Patient Preference and Adherence
Abstract:Asrat Tekle, Arega Tsegaye, Tsige Ketema Jimma University, College of Natural Sciences, Department of Biology, Jimma, Ethiopia Correspondence: Tsige Ketema, Email Background: The scaling-up of antiretroviral therapy (ART) is the greatest accomplishment to reduce the burden of acquired immunodeficiency syndromes (AIDS) to date. However, it requires optimal adherence to be effective. Thus, this study was designed to assess the level of adherence of people living with HIV (PLWH) to ART and its determinants in one of the hardest-hit areas with HIV in Ethiopia. Methods: A health facility-based cross-sectional study design was conducted among adult PLWH, age > 18 years, and receiving ART in southwest Ethiopia. Data was collected by face-to-face interviews following the Self-Rating Scale Item for drug adherence and from participants' medical cards. The effects of variables related to socio-demographic and socio-economic factors, disease and medication, health facilities, and patients' behavior on ART adherence were analyzed using a binary logistic regression model. The data was analyzed using R software. Results: Self-reported good adherence to ART recorded in this study was 73.1% (n =301/412). The risk of poor adherence was significantly higher among those who were divorced, merchants, used ART for longer durationsand were found in stage IV WHO pathogenesis. Contrarily, those who had a positive perception of the effectiveness of ART had significantly better adherence to ART. Longer duration on ART and frequency of pills taken, ≥ 3 pills per day, were significantly associated with a low CD4 + cell count (< 500 cells/mm 3 ). For each unit increase in medication frequency per day, the likelihood of having a high viral load of > 1000 copies/mL was 5.35 times higher. Conclusion: The ART adherence documented in this study was graded as moderately low. Some variables, such as clinical, medical, and behavioral, were found to affect the adherence of people living with HIV to ART. Hence, care providers should be aware of such variables in the process of treatment, follow-up, and monitoring of people living with HIV in the study area. Keywords: Adult, ART, adherence, hospital, HIV/AIDS Human immunodeficiency virus (HIV) is one of the globally emerging viruses and is posing a complex threat to humankind. The virus infects cells of the immune system, impairs their function, and increases susceptibility to various opportunistic infectious agents. 1 Up to 2022 worldwide, the number of people who died since the emergence of this virus was estimated to be 40.4 million; those living with HIV were 39.9 million, and those accessing ART were only 29 million. 2 The incidence rate in 2022 was only 1.3 million globally. 2 Sub-Saharan Africa remains among the hardest hit regions by HIV, with nearly 4.2% of people living with HIV, contributing to about two-thirds of the global total of people living with HIV. 3 Totally, this region contributes about 76% of total HIV infection to the globe. 3 Ethiopia is the second-highest-populated country in Africa. Like any other country in the sub-Saharan region, in Ethiopia, the number of people infected with HIV over the last two decades was estimated to be 943,040. 4,5 However, the country has significantly reduced the HIV burden in the last few years, with overall reduced incidence from 3.3% in 2002 to 0.9% in 2017, and AIDS-related deaths also reduced from 83,000 deaths in 2000 to 15,600 in 2017, 6 following the scaling-up of ART dispensation in almost all regions of the country. 4 In Ethiopia, the highest prevalence was reported from Gambella (4.8%), while the lowest was from Somalia (0.1%). 7,8 Among those aware of their serostatus and diagnosed positive, only 59% were receiving antiretroviral therapy (ART). While a significant proportion of people living with HIV were not using the treatment. 9 However, unlike other chronic conditions, people living with HIV (PLWH) need to be highly adhered (>80% to 95% adherence) to their therapy for the drug to be effective for a long period and to prevent the emergence of resistant viral strains. 10 Hence, poor medication adherence is linked to the development of drug resistance, higher death rates, lower rates of CD4 + cell count, lower therapeutic success, and increased hospitalization. 11 Nonetheless, adherence is a complex health behavior that is influenced by the drug regimen itself, patient and family-related factors, and the patient-health provider relationship. 12 In Ethiopia, different studies have shown that the level of people living with HIV adherence to their treatment varies (between 70% an -Abstract Truncated-
medicine, general & internal